Home
About
Overview
Sharing Data
ORCID
Help
History (8)
Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium.
TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes.
Principal Investigator
Patched-2 Receptor
Bayesian dose-finding in phase I/II clinical trials using toxicity and efficacy odds ratios.
See All 8 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Bayesian dose-finding in phase I/II clinical trials using toxicity and efficacy odds ratios.
Bayesian dose-finding in phase I/II clinical trials using toxicity and efficacy odds ratios. Biometrics. 2006 Sep; 62(3):777-84.
View in:
PubMed
subject areas
Antineoplastic Combined Chemotherapy Protocols
Bayes Theorem
Biometry
Breast Neoplasms
Clinical Trials, Phase I as Topic
Clinical Trials, Phase II as Topic
Dose-Response Relationship, Drug
Female
Humans
Likelihood Functions
Logistic Models
Models, Statistical
Odds Ratio
Toxicology
authors with profiles
Yuan Ji